213 related articles for article (PubMed ID: 25243648)
1. Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index.
Biggins SW; Gralla J; Dodge JL; Bambha KM; Tong S; Barón AE; Inadomi J; Terrault N; Rosen HR
Am J Transplant; 2014 Nov; 14(11):2588-94. PubMed ID: 25243648
[TBL] [Abstract][Full Text] [Related]
2. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D
World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164
[TBL] [Abstract][Full Text] [Related]
4. Liver Retransplantation Associated With Kidney Transplantation for End-stage Liver Graft Disease and Renal Insufficiency: A Morbid Procedure on a Unique Subgroup of Patients.
Cauchy F; Vibert E; Cherqui D; Perdigao F; Sepulveda A; Samuel D; Calmus Y; Conti F; Adam R; Soubrane O; Scatton O
Transplantation; 2020 Jul; 104(7):1403-1412. PubMed ID: 31651789
[TBL] [Abstract][Full Text] [Related]
5. The Evolution of Redo Liver Transplantation Over 35 Years: Analysis of 654 Consecutive Adult Liver Retransplants at a Single Center.
Kaldas FM; Horwitz JK; Noguchi D; Korayem IM; Markovic D; Ebaid S; Agopian VG; Yersiz H; Saab S; Han SB; El Kabany MM; Choi G; Shetty A; Singh J; Wray C; Barjaktarvic I; Farmer DG; Busuttil RW
Ann Surg; 2023 Sep; 278(3):441-451. PubMed ID: 37389564
[TBL] [Abstract][Full Text] [Related]
6. Graft and viral outcomes in retransplantation for hepatitis C virus recurrence and HCV primary liver transplantation: a case-control study.
Martí J; De la Serna S; Crespo G; Forns X; Ferrer J; Fondevila C; Navasa M; Fuster J; García-Valdecasas JC
Clin Transplant; 2014 Jul; 28(7):821-8. PubMed ID: 24806099
[TBL] [Abstract][Full Text] [Related]
7. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients.
Avolio AW; Cillo U; Salizzoni M; De Carlis L; Colledan M; Gerunda GE; Mazzaferro V; Tisone G; Romagnoli R; Caccamo L; Rossi M; Vitale A; Cucchetti A; Lupo L; Gruttadauria S; Nicolotti N; Burra P; Gasbarrini A; Agnes S;
Am J Transplant; 2011 Dec; 11(12):2724-36. PubMed ID: 21920017
[TBL] [Abstract][Full Text] [Related]
8. Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.
Chhatwal J; Samur S; Kues B; Ayer T; Roberts MS; Kanwal F; Hur C; Donnell DM; Chung RT
Hepatology; 2017 Mar; 65(3):777-788. PubMed ID: 27906468
[TBL] [Abstract][Full Text] [Related]
9. How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?
Uemura T; Nikkel LE; Hollenbeak CS; Ramprasad V; Schaefer E; Kadry Z
Transpl Int; 2012 Jun; 25(6):671-9. PubMed ID: 22487509
[TBL] [Abstract][Full Text] [Related]
10. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
[TBL] [Abstract][Full Text] [Related]
11. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
[TBL] [Abstract][Full Text] [Related]
12. The corrected donor age for hepatitis C virus-infected liver transplant recipients.
Dirchwolf M; Dodge JL; Gralla J; Bambha KM; Nydam T; Hung KW; Rosen HR; Feng S; Terrault NA; Biggins SW
Liver Transpl; 2015 Aug; 21(8):1022-30. PubMed ID: 26074140
[TBL] [Abstract][Full Text] [Related]
13. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
[TBL] [Abstract][Full Text] [Related]
14. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
Taniguchi M
Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
[TBL] [Abstract][Full Text] [Related]
16. Donor risk factors in orthotopic liver transplant: analysis of the OPTN/UNOS registry.
Kawakita S; Everly MJ
Clin Transpl; 2013; ():13-22. PubMed ID: 25095488
[TBL] [Abstract][Full Text] [Related]
17. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
18. Utilization of hepatitis C virus infected donors in heart transplant recipients with elevated MELD-XI score.
Hirani R; Okumura K; Isath A; Gregory V; Khan S; Dhand A; Lanier GM; Spielvogel D; Kai M; Ohira S
Clin Transplant; 2023 Dec; 37(12):e15124. PubMed ID: 37688341
[TBL] [Abstract][Full Text] [Related]
19. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
[TBL] [Abstract][Full Text] [Related]
20. The decreasing predictive power of MELD in an era of changing etiology of liver disease.
Godfrey EL; Malik TH; Lai JC; Mindikoglu AL; Galván NTN; Cotton RT; O'Mahony CA; Goss JA; Rana A
Am J Transplant; 2019 Dec; 19(12):3299-3307. PubMed ID: 31394020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
